Didier Hannouche

Fractures of ceramic bearings: history and present status.

During a period of 25 years (1977 to 2001), 13 fractures of an alumina component were recorded retrospectively. During the same period, approximately 5500 alumina components were implanted (3300 with all-alumina bearings and 1200 with alumina-on-polyethylene). These events occurred in seven women and six men, with a mean age of 59 years and a mean weight of 71 kg. There were eight fractures of the femoral head and five fractures of the socket component. Three fractures clearly were related to trauma (two fractures of the socket and one fracture of the head) and two were related to an abnormal design (one 22-mm head and one extra-long neck). Five fractures occurred without any rational explanation, but two fractures that occurred in the early phase could have been caused by a weaker alumina material. Finally three recent fractures of the liner were related to a change in the design of the material. This has been corrected and no additional fractures were observed. Although this dramatic event is of concern, it is infrequent and easy to solve by a limited revision procedure if done emergently. This rare complication should be balanced with the other complications of THR, including mechanical failures and osteolysis, often described with metal-on-polyethylene prostheses.

A meta-analysis of patellar replacement in total knee arthroplasty

From individual randomized studies it is unclear whether the patella should be replaced during total knee replacement. We did a meta-analysis to provide quantitative data to compare patellar resurfacing with nonresurfacing during total knee arthroplasty. Only randomized, controlled trials reported between January 1966 and August 2003 comparing patellar replacement with patella retention were included for a total of 12 studies. Two reviewers assessed trial quality and extracted data from papers. The outcomes identified were reoperations for patellar problems, anterior knee pain, knee scores, stair climbing, and patient satisfaction. The resurfaced patella performed better, and we found an increased relative risk (defined by the ratio of the risk of the event in the resurfaced group on the risk of the event in the nonresurfaced group) for reoperation, for significant anterior knee pain, and for significant pain during stair climbing when the patella was left unresurfaced. No differences were observed between the two groups for International Knee Society function score, Hospital for Special Surgery score, and for patient satisfaction. Despite these general findings, forming a definitive conclusion is difficult because many confounding factors, such as component design, surgeon experience, and technical aspects of the surgery, might influence the result in a patient. Level of Evidence: Therapeutic study, Level II-3 (systematic review. b. Nonhomogeneous Level I studies)

Hybrid alumina total hip arthroplasty using a press-fit metal-backed socket in patients younger than 55 years A SIX- TO 11-YEAR EVALUATION

Between 1990 and 1992, we implanted 71 hybrid alumina-on-alumina hip arthroplasties in 62 consecutive patients under the age of 55 years, with a mean age of 46 years at surgery. There were 56 primary and 15 secondary procedures. The prostheses involved a cemented titanium alloy stem, a 32 mm alumina head, and a press-fit metal-backed socket with an alumina insert. Three patients (four hips) died from unrelated causes. Four hips had revision surgery for either deep infection, unexplained persistent pain, fracture of the alumina head, or aseptic loosening of the socket. The nine-year survival rate was 93.7% with revision for any cause as the end-point and 98.4% with revision for aseptic loosening as the end-point. The outcome in the surviving patients (50 patients, 57 hips) with a minimum five-year follow-up (mean eight years) was excellent in 47 hips (82.5%), very good in eight (14%), good in one and fair in one. A thin, partial, lucent line, mainly in zone III was present in 38% of the sockets and one socket had a complete lucency less than 1 mm thick. One stem had isolated femoral osteolysis. There was no detectable component migration nor acetabular osteolysis. This hybrid arthroplasty gave satisfactory medium-term results in active patients. The press-fit metal-backed socket appeared to have reliable fixation in alumina-on-alumina hip arthroplasty. The excellent results using cemented fixation of the stem may be related to the low production of wear debris.

CURRENT TRENDS IN THE ENHANCEMENT OF FRACTURE HEALING

Repair of fractures involves a sequence of dynamic events which ultimately restores the integrity of the bone and its biomechanical properties. In some cases healing is compromised, leading to delayed union or nonunion. It is estimated that 10% of the fractures which occur annually will require further surgical procedures because of impaired healing. The preferred management of nonunion and bone defects is by autologous cancellous bone grafting, because this provides the essential elements for bone formation, namely living osteogenic cells, bone-inductive proteins which stimulate cell proliferation and differentiation, and a scaffold of apatite which supports the ingrowth of newly formed bone. The supply of suitable bone, however, is limited and its harvest results in additional morbidity to the donor site, leading to pain, haematoma, or infection. For more than 30 years investigators have been developing alternative treatments, by physical or biological methods, aimed at providing the benefits of bone grafting without the complications related to harvest of an autograft. The physical strategy includes the use of mechanical stimulation, electromagnetic fields, and low-intensity ultrasound. The biological approach involves the use of osteoconductive biomaterials, growth factors which stimulate tissue repair (including bone morphogenetic proteins), and osteocompetent cells. We will review the preclinical and clinical data on each therapeutic approach and discuss potential areas of development in the field of bone healing.

Prevention of wear and osteolysis: alumina-on-alumina bearing.

Alumina-on-alumina bearings in total hip replacement have been used for 30 years. Excellent tribologic properties and extra low debris generation could, in theory, provide an answer to osteolysis. A review of the authors’ experience with alumina-on-alumina bearings showed that, except in a few bearings that had been loose for a long time, osteolysis was not a problem. Although the cemented titanium stem and the alumina-on-alumina couple were not a problem, fixation of the socket had to be improved. To improve the socket fixation system and to avoid the use of a cemented titanium stem that may have created problems in the long-term, a new design was introduced in 1997. The current authors present the preliminary results of the first 96 hips with cementless fully-coated hydroxyapatite titanium alloy stems and sockets, 32-mm alumina femoral head, and alumina liner, both held with a Morse taper. Ninety-six consecutive hips in 89 patients (57 males, 32 females) with a median age of 46 years (range, 14–72 years) were analyzed. One socket was revised at 4 months because of poor primary stability in a patient with a severe acetabular fracture. One patient experienced a traumatic fracture of the implanted femur 3 weeks after surgery. The mean followup was 16 months (range, 4–38 months). One patient died from rupture of an aneurysm. Ninety-three hips in 86 patients were assessed regarding the clinical and radiologic ratings. Two patients (two hips) were interviewed by telephone. The Merle d’Aubigné rating system was 18 in 65 hips (59 patients), 17 in 25 hips (25 patients), and 16 in three hips (three patients) mainly related to a previous disability including limp, sciatic palsy, or stiffness. Examination of 93 available radiographs revealed no ostelolysis, no radiolucent lines at the last examination, and no subsidence. The level of excellent results, even in this young population, and lack of osteolysis and wear are encouraging, even if the followup is too short to allow any conclusions to be made.

Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis.

OBJECTIVE To characterize bone microarchitectural changes and to test the hypothesis that disrupting local cytokine equilibrium could modify cartilage degradation in a murine model of experimental osteoarthritis (OA). METHODS Ten-week-old male C57BL/6 mice underwent medial meniscectomy of their right knees and a sham operation of their left knees. The mice received intraperitoneal injections of osteoprotegerin (OPG) (10 mg/kg), interleukin-1 receptor antagonist (IL-1Ra) (100 mg/kg), or phosphate buffered saline for 6 weeks. The microarchitecture of the trabecular bone, the OA score, and expression of ADAMTS-4 and ADAMTS-5 were assessed. Proteoglycan release was measured in cartilage explant cultures in the presence of IL-1Ra and OPG. RESULTS In the meniscectomized knees, bone volume/tissue volume (BV/TV) was lower, whereas trabecular separation, the OA score, and aggrecanase expression were higher than in the sham-operated knees. After treatment with OPG, BV/TV was significantly increased and trabecular separation was reduced in the knees that underwent meniscectomy. The OA score and the number of ADAMTS-positive cells were significantly decreased by treatment with OPG but were not affected by IL-1Ra. Moreover, OPG did not directly reduce the release of proteoglycans from cartilage explant cultures. CONCLUSION In an experimental model of OA, meniscectomy induced bone loss and cartilage degradation at 6 weeks. Systemic administration of OPG prevented bone and cartilage degradation in vivo but had no effect on cartilage in vitro. These data collectively indicate that bone could be a contributor in the early stages of OA pathogenesis. They further suggest that disruption of RANKL/OPG balance might result in the degradation of cartilage subjected to mechanical loading. Specific targeting of the bone cytokine network might help to prevent OA.

Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling.

Background Osteoarthritis (OA) is characterised by cartilage degradation and bone lesions. Subchondral bone may be involved in the pathogenesis of cartilage matrix breakdown. Objective To assess the role of bone remodelling in OA by studying the effect of bisphosphonate on OA development in mice with high bone remodelling. Methods Mice overexpressing Runx2 (Runx2-Tg) under the control of collagen type I that displayed high bone remodelling were used. Joint instability was performed by partial medial meniscectomy to induce OA. Results Six weeks after surgery, tibial cartilage of Runx2-Tg mice displayed an increased number of ADAMTS-4- and ADAMTS-5-expressing chondrocytes compared with controls (p<0.05). This increase was higher in Runx2-Tg mice than in wild-type mice, although their OA score did not differ (2.5±0.6 vs 2.4±0.2, P=NS). Pamidronate reduced the OA score in Runx2-Tg mice but not in wild-type littermates (1.2±0.5 vs 2.7±0.4; p<0.05) despite the reduction of bone resorption and of the expression of cartilage proteases in both genotypes. Conclusions These findings support the hypothesis that the level of bone resorption influences cartilage metabolism and that inhibition might prevent the progression of OA. Targeting bone resorption might therefore provide an approach to the treatment of high bone resorbing forms of OA.

In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye.

Recent advances in the field of tissue engineering have culminated in new tissue substitutes that combine a biomaterial and precursor cells. The effectiveness of these materials is generally assessed in animals, but few studies explore the fate of the transplanted cells in vivo, despite its paramount importance for understanding the function of the engineered tissues. Current methods that use reporter genes or chimeric animals are not always well suited to solving tissue-engineering problems. We therefore developed a new method for irreversible labeling of cells to track their fate in vivo. We used a fluorescent lipophilic probe, CM-Dil, that avidly binds to the cell membrane. Human bone marrow stromal fibroblasts could be labeled with 20 microM CM-Dil in 30 min. The CM-Dil was not cytotoxic and did not affect cell proliferation in vitro. Cells could be monitored for up to 30 days when placed in a coral scaffold and implanted intramuscularly or in a bony site. However, the fluorescence intensity decreased roughly in parallel with the number of cell divisions. This fact needs to be taken into account during the design and interpretation of experiments. We believe that this technique is also of interest for other cell types.

Use of the induced membrane technique for bone tissue engineering purposes: animal studies.

Animal experiments using the induced membrane procedure for bone tissue engineering purposes have provided evidence that the membrane has structural characteristics and biologic properties that may be used for bone tissue engineering purposes. Clinically relevant animal models have demonstrated that standardized particulate bone constructs can be used to repair large bone defects using the procedure and that the osteogenic ability of these constructs partially approaches that of bone autografts.

Long-term results of alumina-on-alumina hip arthroplasty for osteonecrosis.

Alumina-on-alumina bearings in THR may, in theory, provide an effective answer to osteolysis in young patients with ON of the femoral head. The purpose of this retrospective study was to report the long-term results of a series of 52 consecutive alumina THAs (41 patients) done for ON. The mean age of the patients at surgery was 41 years (range, 22–79 years). Cemented femoral stems with a 32-mm alumina head were used. Plain alumina cups were used and were either cemented (39 hips) or press-fit (13 hips). No patients were lost to followup. Sixteen hips have been revised. Aseptic loosening of the socket was the main cause of failure. At an average 16-year followup (range, 11–23.65 years), 26 hips were rated excellent and one hip was rated good. No osteolysis was observed and wear was undetectable. If revision for aseptic loosening was the end point, the rate of survival was 88.5% at 10 years for the socket and 100% at 10 years for the stem. With the alumina-on-alumina hip replacement done for ON, absence of osteolysis can be expected for as many as 24 years after the operation. New methods of socket fixation now are being explored.